Takeda

Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
Yahoo/BusinessWire
Sat, 11/12/11 - 12:16 pm
peginesatide
chronic kidney disease
dialysis
Affymax
Takeda
10 largest upcoming pharma patent losses in the US
Fierce Pharma
Tue, 10/25/11 - 11:54 am
Takeda
Actos
Forest Labs
Lexapro
Bristol-Myers Squibb
Plavix
AstraZeneca
Seroquel
Eli Lilly
Zyprexa
Pfizer
Lipitor
Merck
Singulair
Novartis
Diovan
Provigil
Teva Pharmaceuticals
Abbott Laboratories
TriCor
Takeda starts Phase III trials of first-in-class diabetes drug
Pharma Times, UK
Wed, 10/19/11 - 12:02 pm
Takeda
diabetes
TAK-875
Takeda Eyes Nycomed Integration Before Another Deal
WSJ
Sat, 10/15/11 - 01:04 pm
Nycomed
Takeda
5 promising pancreatic cancer drugs
Fierce Biotech
Thu, 10/13/11 - 01:23 pm
Amgen
Takeda
Ganitumab
KAEL-GemVax
GV1001
HyperAcute Pancreas
NewLink Genetics
GI-4000
GlobeImmune
MM-398
Merrimack Pharmaceuticals
pancreatic cancer
China Biotech Week In Review: Sinovac Begins Foray Into Animal Health Vaccine
Seeking Alpha
Sun, 10/2/11 - 12:45 pm
Sinovac
animal health
Cardinal Health
Sanjiu Medical and Pharmaceutical
Guangdong Zhongsheng Pharma
Takeda
Merck
Takeda Completes Acquisition and Names New CEO of Nycomed
PR Newswire
Fri, 09/30/11 - 12:09 pm
Takeda
Nycomed
M&A
Takeda in talks with Lupin, Cipla to buy pharma businesses
Stock Market Digital
Wed, 08/24/11 - 10:47 am
M&A
Cipla
Lupin
Takeda
India
Flu vaccine subsidy for Takeda
PM Live
Tue, 08/23/11 - 10:57 am
Flu
vaccines
flu vaccine
Takeda
Japan
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Drug Maker Dividend Stocks With Strong Growth Prospects
Seeking Alpha
Wed, 08/10/11 - 10:47 am
Pfizer
Merck
Bristol-Myers Squibb
Novartis
Takeda
Sanofi
Eli Lilly
GSK
Roche
AstraZeneca
dividends
Wave of lawsuits follow warnings that top-selling diabetes drug may raise bladder cancer risk
Yahoo/AP
Mon, 08/8/11 - 12:30 pm
bladder cancer
diabetes
Takeda
Actos
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Fri, 08/5/11 - 01:17 pm
Takeda
pramlintide/metreleptin
obesity
Amylin
New Nycomed US chief aims to grow by M&A
Fierce Pharma
Tue, 08/2/11 - 08:21 pm
M&A
Nycomed
Pharma CEOs
Takeda
Brian Markison
Takeda heads back to FDA with diabetes blockbuster hopeful
Fierce Biotech
Tue, 07/26/11 - 04:43 pm
FDA
diabetes
Takeda
alogliptin
Key blockbuster drugs about to get generic rivals
Yahoo/AP
Mon, 07/25/11 - 09:10 am
generics
Eli Lilly
Forest Labs
Pfizer
AstraZeneca
Cephalon
Bristol-Myers Squibb
Sanofi
patents
Abbott Laboratories
Merck
Takeda
Novartis
Endo
GSK
Good news, bad news from diabetes gathering
Fierce Pharma
Tue, 06/28/11 - 09:26 am
diabetes
Takeda
GSK
Merck
Eli Lilly
Takeda's Actos, Glaxo's Avandia Raise Risk of Eye Disease
San Francisco Gate, CA
Sat, 06/25/11 - 11:22 am
Takeda
Actos
GSK
Avandia
macular edema
diabetes
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thu, 06/23/11 - 09:12 am
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
When Two Cancer Drugs Are Better Than One
Bloomberg Businessweek
Fri, 06/17/11 - 10:17 am
Merck
AstraZeneca
Eli Lilly
Roche
GSK
Takeda
cancer
Bristol-Myers Squibb

Pages